McCray & Co. Competitors

All at the same table. All on your side. At Pinnacle, we pride ourselves on being more than just financial advisors. We are your collaborators in precision and your trusted delegates on the path to comprehensive wealth management. We illuminate the complexities of financial planning, guiding you through every step. In coordination with professionals, we fuse our strengths to meet your unique financial needs. As our valued client, you are at the heart of our commitment. Your finances are not simply a footnote in reaching a final destination, but a valuable component in the story of your life. We’re here to help you embrace and achieve each milestone together. Let us help you worry-free planning for a secure tomorrow with services including: - Wealth Management - Trust Management - Corporate Trusts - Company Retirement Plans - Wealth Collaboration - Institutional Investing Reach out to learn more about Pinnacle Advisors or explore our website at: https://www.pinnacleadvisors.com Pinnacle is a fee-only Wealth Management firm working with affluent individuals, business owners and their families. Pinnacle sells no products and receives no income from any third party. Pinnacle is an SEC Registered Investment Adviser, which legally makes Pinnacle a FIDUCIARY to its clients under both state and federal law.

We built Johnson Consulting Group to address all of the operational and financial needs of our funeral home and cemetery clients. We are the only company in the funeral home consulting business that offers solutions to every aspect of your company. Johnson Consulting Group is your total solutions funeral business consulting firm!

Quattro’s single focus is on helping healthcare companies accelerate growth. Since our founding, we have worked exclusively in biopharmaceuticals and medical technology, so we know the healthcare landscape very well. From Fortune 500 to early-stage, our client work has included assessing business development opportunities, identifying new growth paths, conducting due diligence, evaluating pricing and positioning, and many other strategic issues. In addition, we have worked extensively with some of the most highly respected, widely known biotech investors on Wall Street to analyze prospective and current investments and independently verify assumptions. We have a reputation for being exceptionally good at assessing the strategic, quantitative, and marketing implications of how and why physicians decide among different treatment options, including those that compete either directly or indirectly. Quattro has analyzed opportunities in oncology, cardiology, dermatology, neurology, immunology, nephrology, hematology, endocrinology, infectious diseases, orthopedic surgery, general surgery, radiology, gastroenterology, and many others. We dive deeply into the detailed aspects of competitive opportunities for investigational and commercially available drugs, devices, and diagnostics. This often includes, for example, clinical trial results, prevalence and incidence data, mechanisms of action, segmentations of disease pathophysiology and patient symptoms, patterns in physician referrals and decision-making, and more. We weave this in-depth understanding into rigorously quantitative market models that help predict growth, gauge sensitivities, and prioritize actions. Compared to our competitors, Quattro’s depth of experience delivers answers that are more pragmatic, insightful, and on-target. Lastly, our clients consistently tell us how much they appreciate our uniquely individualized attention: Quattro’s managing directors personally lead every client project.